JP Morgan Chase’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,859
Closed -$77K 5384
2017
Q2
$77K Sell
1,859
-9,252
-83% -$330K ﹤0.01% 4246
2017
Q1
$346K Sell
11,111
-4,000
-26% -$136K ﹤0.01% 3859
2016
Q4
$528K Buy
+15,111
New +$479K ﹤0.01% 3742
2016
Q3
Sell
-2,524
Closed -$58K 5018
2016
Q2
$58K Buy
2,524
+1,268
+101% +$30.2K ﹤0.01% 4016
2016
Q1
$30K Buy
1,256
+730
+139% +$17.7K ﹤0.01% 4013
2015
Q4
$14K Buy
+526
New +$12.9K ﹤0.01% 4149

JP Morgan Chase's NUTR Position: Q3 2017 in Review

JP Morgan Chase sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 1,859 shares — an estimated $77K sold.

JP Morgan Chase first reported a position in NUTR in Q4 2015 and held it in 6 quarters. The position peaked at $528K in Q4 2016. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.

  • JP Morgan Chase reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
  • JP Morgan Chase sold 1,859 Nutraceutical International Co shares in Q3 2017, an estimated $77K.
  • JP Morgan Chase first reported a position in Nutraceutical International Co in Q4 2015 and held it in 6 quarters.
  • JP Morgan Chase's Nutraceutical International Co position peaked at $528K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.

Based on JP Morgan Chase's 13F filing for Q3 2017, filed 9 Nov 2017.